Skip to content
Disclosery

TPG GP A, LLC

Follow

13F filer, CIK 1903793, FORT WORTH, TX

TPG GP A, LLC reported $1,836,145,807 across 9 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001999371-25-017885

Period
2025-09-30
Reported value
$1.84B
Holdings
9
Top 10 weight
100%
New
0
Sold out
0

Part of the filer group TPG GP A, LLC

How groups are built

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
LTHreduced-3,573,836-$98.6M
TRTXreduced-4,693,916-$40.2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001999371-25-017885, largest first. % of portfolio is the value over $1,836,145,807, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LFSTLIFESTANCE HEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 160,711,618 shares; 2024Q4: 160,711,618 shares; 2025Q1: 160,711,618 shares; 2025Q2: 160,711,618 shares; 2025Q3: 160,711,618 shares 160,711,618$884M48.14%0Timeline
LTHLIFE TIME GROUP HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 39,494,730 shares; 2024Q4: 36,816,205 shares; 2025Q1: 29,748,906 shares; 2025Q2: 21,404,488 shares; 2025Q3: 17,830,652 shares 17,830,652$492M26.8%-3,573,836Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 6,684,962 shares; 2025Q2: 6,744,962 shares; 2025Q3: 6,744,962 shares 6,744,962$198M10.8%0Timeline
AMRXAMNEAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 12,328,767 shares; 2024Q4: 12,328,767 shares; 2025Q1: 12,328,767 shares; 2025Q2: 12,328,767 shares; 2025Q3: 12,328,767 shares 12,328,767$123M6.72%0Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,010,425 shares; 2024Q4: 3,010,425 shares; 2025Q1: 3,010,425 shares; 2025Q2: 3,010,425 shares; 2025Q3: 3,010,425 shares 3,010,425$47.5M2.59%0Timeline
CBLLCERIBELL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 3,967,422 shares; 2025Q1: 3,967,422 shares; 2025Q2: 3,967,422 shares; 2025Q3: 3,967,422 shares 3,967,422$45.6M2.48%0Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 18,716,306 shares; 2024Q4: 18,716,306 shares; 2025Q1: 18,716,306 shares; 2025Q2: 18,716,306 shares; 2025Q3: 18,716,306 shares 18,716,306$23.2M1.26%02026-09-28, 13D/A: 0 shares, 0% of the class, 13D/A filed 2026-09-30 Timeline
TRTXTPG RE FIN TR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,086,779 shares; 2024Q4: 7,086,779 shares; 2025Q1: 7,086,779 shares; 2025Q2: 7,086,779 shares; 2025Q3: 2,392,863 shares 2,392,863$20.5M1.12%-4,693,916Timeline
RALLYBIO CORPRALLYBIO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,028,414 shares; 2024Q4: 3,028,414 shares; 2025Q1: 3,028,414 shares; 2025Q2: 3,028,414 shares; 2025Q3: 3,028,414 shares 3,028,414$1.51M0.08%0

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001999371-25-017885 base2025-11-14acceptance time not in the bulk data set